Developing Antiangiogenic Peptide Drugs for Angiogenesis-Related Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|20|2074-2086

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.20, 2007-07, pp. : 2074-2086

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiogenesis: New Opportunities and Solutions for Drug Development. Predictive markers for antiangiogenic drugs

By Gerber Hans-Peter  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 12, 2003-12 ,pp. : 2001-2004

Informa Healthcare

Access to resources Recommend Favorite

Angiogenesis-related molecular targets in esophageal cancer

By Hong Liu   Li Shujun   Han Yu   Du Jianjun   Zhang Hongwei   Li Jipeng   Zhao Qingchuan   Wu Kaichun   Fan Daiming  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 5, 2011-05 ,pp. : 637-644

Informa Healthcare

Access to resources Recommend Favorite

Putative effects of potentially anti-angiogenic drugs in rheumatic diseases

By Maruotti Nicola   Cantatore Francesco   Ribatti Domenico  

European Journal of Clinical Pharmacology, Vol. 70, Iss. 2, 2014-02 ,pp. : 135-140

Springer Publishing Company

Access to resources Recommend Favorite

The Role of Estrogen and Estrogen-Related Drugs in Cardiovascular Diseases

By  

Current Drug Metabolism, Vol. 4, Iss. 6, 2003-12 ,pp. : 497-504

Bentham Science Publishers

Access to resources Recommend Favorite

Colon cancer angiogenesis and antiangiogenic therapy

By Wray Curtis J   Rilo Horatio L   Ahmad Syed A  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 6, 2004-06 ,pp. : 631-641

Informa Healthcare

Access to resources Recommend Favorite